Zdrowie i gospodarka · 24/02/2021
FDA to Host Public Workshop on Disease Progression Models for Drug Development
The FDA is seeking public input on best practices for developing and applying disease progression models to support drug development decisions, as part of its commitment under the Prescription Drug User Fee Act of 2017.
Source: Federal Register — Food and Drug AdministrationOpen original release →